Part of EPR's Wellness PR pillar · Related entity profiles: Oura · Calm
Originally published June 2026. Updated October 2026.
Athletic Greens (AG1): The Wellness Brand the Chatbot Recommends First
Athletic Greens (AG1) is the wellness brand AI engines name first across the largest share of consumer wellness prompts. The New Zealand-founded, U.S.-headquartered greens powder operator carries the highest modeled Citation Share of any wellness brand EPR has tested, ranking #1 across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews on prompts ranging from "best greens powder" to "best supplement according to Andrew Huberman" to "best multivitamin replacement." The brand operates through subscription-only direct-to-consumer commerce with no traditional retail distribution, and represents one of the most-studied wellness commercial cases of the modern era. This is EPR's entity reference on AG1.
Corporate Background
Athletic Greens was founded in 2010 by Chris Ashenden in Auckland, New Zealand. Ashenden's founding insight was that the proliferation of single-nutrient supplements left consumers unable to confidently assemble a comprehensive daily nutritional foundation. The Athletic Greens product, marketed since the brand's full rebrand as AG1, combined 75 vitamins, minerals, whole-food source ingredients, probiotics, and adaptogens into a single daily powder.
The brand grew slowly across the early 2010s through health-and-fitness community word-of-mouth before scaling dramatically with the podcast-advertising model that became its commercial flywheel from approximately 2016 onward. The brand rebranded as AG1 in 2022 to consolidate around a single product positioning. Kat Cole joined as President and COO in December 2021 and serves as CEO as of 2026.
The Product
AG1 is a single-product brand. The daily powder, a single approximately-12-gram serving, contains 75 active ingredients including vitamins, minerals, adaptogens, mushroom complex, probiotics, and whole-food sourced micronutrients. The product is positioned as a comprehensive daily nutritional foundation that consolidates the function of a multivitamin, a greens powder, a probiotic, and adaptogenic supplements into a single subscription.
The product carries NSF Certified for Sport credentialing, the certification standard for athletic and clinical-grade supplements, more rigorous than general NSF certification. The credentialing has been one of the brand's most-cited credibility anchors and is a structural input to AG1's AI engine retrieval position.
How big is AG1, and how is it sold?
AG1 operates on a subscription direct-to-consumer model. The product is not available through Amazon, retail health stores, or other third-party channels. Subscription customers receive a monthly shipment with welcome-kit accessories (the branded scoop, the branded shaker bottle, the branded canister). Subscription pricing runs $79 to $99 per month depending on tier.
Revenue figures differ by source. Industry estimates place AG1's annual revenue above $400 million as of 2025, while Fortune reported in January 2025 that the brand was projecting $600 million in revenue for that fiscal year. Subscription-only distribution removes retail intermediaries and their margin demands, which lets AG1 reinvest directly in podcast advertising.
How does AG1's podcast advertising engine work?
AG1's commercial scale has been built primarily through podcast advertising, beginning with placements on The Tim Ferriss Show and The Joe Rogan Experience in the mid-2010s and expanding to virtually every major health, wellness, longevity, and performance podcast across the past decade. Andrew Huberman, Peter Attia, Rich Roll, Lex Fridman, Lewis Howes, and dozens of additional creators have run sustained AG1 advertising programs over multi-year relationships.
Marketing analysis firm Ampifire estimates AG1 spends approximately $2.2 million per month on podcast placements, and Marketing Brew reported in 2025 that AG1's Chief Revenue Officer, Jonathan Corne, described the company as working with "hundreds" of podcasters at any given time. Each show gets a customized landing page, so a listener arriving from The Tim Ferriss Show sees "Recommended by Tim Ferriss" and his photo, according to marketing analysis site OptimonK.
The advertising frequency, the same recommendation repeated across hundreds of episodes by trusted credentialed voices, has produced a corpus signal that AI engines now retrieve as endorsement context rather than as advertising context. This is the central structural insight of the AG1 commercial case.
The AI Engine Retrieval Position
AG1 ranks #1 in EPR's modeled Wellness AI Citation Share Study across the broadest set of consumer wellness prompts. The brand dominates in: "best greens powder" (universal #1), "best supplements according to Andrew Huberman" (anchored by the sustained Huberman partnership), "best comprehensive multivitamin" (a category the brand has effectively created), "is AG1 worth the price," and "best subscription supplement."
The retrieval depth is exceptional and structurally hard to displace. A new entrant in the greens powder category would need to invest at the AG1 scale of podcast advertising for multiple years before reaching equivalent retrieval position.
What legal and reputation risks does AG1 face?
AG1's retrieval position carries notable critique context alongside the positive endorsement signal. The AI engines surface skeptical analysis of the brand's pricing (AG1 is materially more expensive than commodity multivitamins for arguably overlapping ingredient profiles), the brand's reliance on podcast advertising as endorsement substrate, and the broader question of whether comprehensive greens powders deliver outcomes superior to whole-food nutrition or simpler multivitamins.
The same concentration that built AG1's moat also creates exposure. A class-action lawsuit filed in California and reported by ClassAction.org in February 2026 alleges the company enrolled customers in recurring subscriptions without clear consent. A separate investigation reported by LawGud in mid-2025 alleges AG1 overstated the comprehensiveness of its nutritional claims and the meaningfulness of its probiotic content. These are allegations, not findings.
In June 2026, longevity entrepreneur Bryan Johnson publicly challenged AG1's clinical evidence, citing a company-funded four-week trial of 30 participants that he said showed no meaningful health improvement, in a post that drew more than 1.4 million views, according to reporting by Calfkicker. A brand built on borrowed credibility from podcast hosts is also exposed whenever a host's own reputation comes under question. Other mid-size consumer brands can take three lessons: concentrate spend where trust compounds over years, build a certification anchor like NSF Certified for Sport that can absorb skepticism, and track host reputational risk as a standing line item.
The critique surface is not damaging in the way controversy-tagged brands face. The engines surface AG1's positive endorsement context substantially more frequently than the critique context. But the critique is durable and surfaces consistently.
